New study by Professor Yoon-Kyoung Cho validates urine-based biomarkers for early detection of cancer.
A team of researchers, led by Professor Yoon-Kyoung Cho of Life Science at UNIST has recently developed a new technique that effectively identifies cancer-causing substances in the urine or blood.
In the study, Professor Yoon-Kyoung Cho of Life Science, a group leader at IBS Research Center for Soft and Living Matter (CSLM) presented an integrated centrifugal microfluidic
platform (Exodisc), a device that isolates extracellular vesicles (EVs) from urine.
The results of the study has been published in the February issue of ACS Nano journal. The research team expects that this may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics.
Despite the increasing clinical importance of EVs as potential biomarkers in the diagnosis and prognosis of various diseases, current methods of EV isolation and analysis suffer from complicated procedures with long processing times. For instance, even ultracentrifugation (UC), the most commonly used method for EV isolation, requires time-consuming steps involving centrifugation and acquisition of large sample volumes, and the results suffer from low yield and purity.
To overcome these limitations, Professor Cho presented a new lab-on-a-disc platform for rapid, size-selective, and efficient isolation and analysis of nanoscale EVs from raw biological samples, such as cell-culture supernatant (CCS) or cancer-patient urine.
“The Exodisc is compoased of two independent filteration units (20nm and 600nm in size) within a disk-shaped chip to enable the processing of two different samples simulateously,” says Hyun-Kyung Woo (Combined M.S./Ph.D. student of Natural Science), the first author of the study. “Upon spinning the disc, the urine sample is transferred through two integrated nanofilters, allowing for the enrichment of unirary EVs within the size range of 20 to 600 nm.”
The hole sizes in nanoporous filters mounted on the Exodisc were set arbitrarily to seperate the nanoscale vesicles effectively from germs or unnecessary proteins. The direct detection of urinary EVs from patients with bladder cancer was validated successfully, using on-disc enzyme-linked immunosorbent assay (ELISA).
“Using Exodisc, it is possible to isolate EVs from raw samples within 30 minutes,” says Professor Cho. “The process of passing the filter through centrifugal force is automatically carried out, effectively recovering the enriched EVs.”
In the study, the research team examined clinical samples by analyzing urinary EVs from bladder cancer patients, using a tabletop-sized centrifugal microfluidic system. As a result, fully automated enrichment of unirary EVs in the size range of 20?600 nm was achieved within 30 min Quantitative tests.
“On-disc ELISA using urinary EVs isolated from bladder cancer patients showed high levels of CD9 and CD81 expression, suggesting that this method may be potentially useful in clinical settings to test urinary EV-based biomarkers for cancer diagnostics,” says Vijaya Sunkara of Life Sciences, the co-first author.
“We are currently conducting further studies to determine various diseases, including cancer by analyzing the collected nanoparticles,” says Professor Cho. “We hope this device can contribute significantly to the advancement of studies related to tumor biology and acceleration of the practical use of EV-based liquid biopsies for personalized medicine in clinical settings,” says Professor Cho.
Receive an email update when we add a new CANCER DIAGNOSTICS article.
The Latest on: Cancer diagnostics
via Google News
The Latest on: Cancer diagnostics
- Ciara’s Mega Mission: Stopping Cervical Cancer In Black Womenon July 2, 2021 at 4:35 pm
Black women are twice as likely to die from cervical cancer compared to white women. Grammy-winning artist, Ciara, is on a mission to saving Black and brown women and changing history.
- Couple marries in North Carolina after cancer diagnosis | Charlotte Observeron July 2, 2021 at 1:14 pm
A North Carolina couple delayed their wedding due to COVID-19 — then faced another health scare. Just months before the rescheduled ceremony, groom Cam Hughes said he wasn’t feeling well and went to ...
- Cancer symptoms: Professor warns of two of the biggest symptoms warning of your riskon July 2, 2021 at 9:33 am
CANCER symptoms and signs can often be nondescript as most will not know which body part is being affected. Many times, the cancer in a certain body part could cause symptoms in a different body part ...
- How Linda Laughlin’s cancer diagnosis inspired foundationon July 2, 2021 at 9:19 am
NBCSW’s Capitals analyst Craig Laughlin saw his wife go through months’ worth of cancer treatments. Now, they have a foundation to help others.
- NPR’s Ina Jaffe Shared Her Breast Cancer Journey, Couple Moves Up Their Wedding After Cancer Diagnosis and Moreon July 2, 2021 at 8:00 am
From Ina Jaffe’s breast cancer news to a couple moving up their wedding due to a cancer diagnosis, here’s what’s happening in the cancer landscape this week.
- LabCorp launches diagnostic for new lung cancer therapyon July 2, 2021 at 3:27 am
Labcorp (NYSE: LH)'s new test expands the firm's testing solutions for new precision medicines used to treat patients with lung cancer.
- Why Didn’t My Friend Tell Me About Her Cancer Diagnosis?on July 1, 2021 at 6:00 am
A reader wonders how to be a supportive friend without transgressing privacy boundaries. A friend of mine was recently diagnosed with ovarian cancer. The problem: She hasn’t told me. (I overheard her ...
- Israeli Hospital Pilots Rapid Diagnosis Of Blood Cancer With Sight Diagnosticson July 1, 2021 at 5:05 am
Sight Diagnostics will partner with Shaare Zedek Medical Center to detect blood cancer with AI tech and patient information.
- Cancer Diagnostics Market Estimated to Cross US$ 311.1 BN by 2027on June 29, 2021 at 11:47 pm
TMR has published a new report titled Cancer Diagnostics Market Global Industry Analysis Size Share Growth Trends and Forecast 2019 2027 According to the report the global cancer diagnostics market ...
via Bing News